← All companies

PRRU

Immutep Limited

PRRUF Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.05

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$73.0M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.04 – $0.33

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Aug 3, 2026 6-K Jul 14, 2026 6-K Jun 5, 2026 6-K May 1, 2026 6-K May 1, 2026 6-K Apr 16, 2026 6-K Mar 20, 2026 6-K Mar 16, 2026 6-K Feb 26, 2026 6-K Feb 10, 2026 6-K Jan 30, 2026 6-K Dec 23, 2025 6-K Dec 17, 2025 6-K FORM 6-K Dec 9, 2025 6-K FORM 6-K Dec 3, 2025 6-K FORM 6-K Nov 14, 2025 6-K Nov 4, 2025 6-K Oct 30, 2025 20-F Oct 24, 2025 6-K Oct 21, 2025 6-K Oct 21, 2025 6-K Oct 14, 2025 6-K Oct 9, 2025 6-K Sep 23, 2025 6-K Sep 3, 2025 6-K Aug 7, 2025 6-K Jul 31, 2025 6-K Jun 24, 2025 6-K May 28, 2025 6-K May 16, 2025 6-K May 6, 2025 6-K Apr 30, 2025 6-K Mar 26, 2025 6-K Feb 27, 2025 6-K Feb 3, 2025 6-K Dec 17, 2024 6-K FORM 6-K Dec 12, 2024 6-K Dec 10, 2024 6-K Nov 15, 2024 6-K Nov 15, 2024